|
Dosage/Direction for Use
Oral Cerebrovascular insufficiency, Functional rehabilitation after cerebrovascular accidents, Auditory, vestibular and visual disorders of ischaemic aetiology Adult: Each tablet contains almitrine 30 mg and raubasine 10 mg. Recommended dosage: 1 tablet bid. |
|
Contraindications
Concurrent usage with MAOIs.
|
|
Special Precautions
Pregnancy. Long term treatment may result in numbness, prickling or formication effects in the lower limbs which may, in rare cases, lead to treatment withdrawal.
|
|
Adverse Reactions
Mild GI disorders, sleep disturbances, palpitations, anxiety, dizziness. Rarely, wt loss, peripheral neuropathy with abnormal sensations in the lower limbs.
|
|
Overdosage
Signs include tachycardia, arterial hypotension, polypnoea and respiratory alkalosis. Treatment consists of gastric lavage and symptomatic supportive measures. Cardiopulmonary observation with repeated monitoring of blood gases are recommended.
|
|
Drug Interactions
Not to be used concurrently with other almitrine-containing preparations.
Potentially Fatal: MAOIs. |
|
Action
Almitrine and raubasine work together to increase the amount of oxygen brought to the brain and neurosensory tissue, by increasing the oxygen content of arterial blood.
|
Sign Out
